Luke Tomasovic

Mr. Luke Tomasovic

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2024 in Nature
Verified
Journal Article
Open access
PDF file
BHBuwei Huang
Buwei Huang
MAMohamad Abedi
Mohamad Abedi
GAGreen Ahn
Green Ahn
BCBrian Coventry
Brian Coventry
ISIsaac Sappington
Isaac Sappington
DBDavid Baker
David Baker
Endocytosis and lysosomal trafficking of cell surface receptors can be triggered by endogenous ligands. Therapeutic approaches such as lysosome-targeting chimaeras1,2 (LYTACs) and cytokine receptor-targeting chimeras3 (KineTACs) have used this to target specific proteins for degradation by fusing modified native ligands to target binding proteins. Although powerful, these approaches can be limited by competition with native ligands and requirements for chemical modification that limit genetic encodability and can complicate manufacturing, and, more generally, there may be no native ligands that stimulate endocytosis through a given receptor. Here we describe computational design approaches for endocytosis-triggering binding proteins (EndoTags) that overcome these challenges. We present EndoTags for insulin-like growth factor 2 receptor (IGF2R) and asialoglycoprotein receptor (ASGPR), sortilin and transferrin receptors, and show that fusing these tags to soluble or transmembrane target protein binders leads to lysosomal trafficking and target degradation. As these receptors have different tissue distributions, the different EndoTags could enable targeting of degradation to different tissues. EndoTag fusion to a PD-L1 antibody considerably increases efficacy in a mouse tumour model compared to antibody alone. The modularity and genetic encodability of EndoTags enables AND gate control for higher-specificity targeted degradation, and the localized secretion of degraders from engineered cells. By promoting endocytosis, EndoTag fusion increases signalling through an engineered ligand–receptor system by nearly 100-fold. EndoTags have considerable therapeutic potential as targeted degradation inducers, signalling activators for endocytosis-dependent pathways, and cellular uptake inducers for targeted antibody–drug and antibody–RNA conjugates.

29 September 2023 in Science Immunology
Verified
Journal Article
Closed access
ADArbor G. Dykema
Arbor G. Dykema
JZJiajia Zhang
Jiajia Zhang
LCLaurene S. Cheung
Laurene S. Cheung
SCSydney Connor
Sydney Connor
BZBoyang Zhang
Boyang Zhang
KSKellie N. Smith
Kellie N. Smith
Regulatory T cells (Treg) are conventionally viewed as suppressors of endogenous and therapy-induced antitumor immunity; however, their role in modulating responses to immune checkpoint blockade (ICB) is unclear. In this study, we integrated single-cell RNA-seq/T cell receptor sequencing (TCRseq) of >73,000 tumor-infiltrating Treg(TIL-Treg) from anti–PD-1–treated and treatment-naive non–small cell lung cancers (NSCLC) with single-cell analysis of tumor-associated antigen (TAA)–specific Tregderived from a murine tumor model. We identified 10 subsets of human TIL-Treg, most of which have high concordance with murine TIL-Tregsubsets. Only one subset selectively expresses high levels ofTNFRSF4(OX40) andTNFRSF18(GITR), whose engangement by cognate ligand mediated proliferative programs and NF-κB activation, as well as multiple genes involved in Tregsuppression, includingLAG3. Functionally, the OX40hiGITRhisubset is the most highly suppressive ex vivo, and its higher representation among total TIL-Tregcorrelated with resistance to PD-1 blockade. Unexpectedly, in the murine tumor model, we found that virtually all TIL-Treg–expressing T cell receptors that are specific for TAA fully develop a distinct TH1-like signature over a 2-week period after entry into the tumor, down-regulatingFoxP3and up-regulating expression ofTBX21 (Tbet), IFNG, and certain proinflammatory granzymes. Transfer learning of a gene score from the murine TAA-specific TH1-like Tregsubset to the human single-cell dataset revealed a highly analogous subcluster that was enriched in anti–PD-1–responding tumors. These findings demonstrate that TIL-Tregpartition into multiple distinct transcriptionally defined subsets with potentially opposing effects on ICB-induced antitumor immunity and suggest that TAA-specific TIL-Tregmay positively contribute to antitumor responses.

31 May 2019 in Journal of Materials Chemistry A
Verified
Journal Article
Closed access
PDF file
SHSajad Haghanifar
Sajad Haghanifar
LTLuke Tomasovic
Luke Tomasovic
AGAnthony J. Galante
Anthony J. Galante
DPDavid Pekker
David Pekker
PLPaul W. Leu
Paul W. Leu
In this paper, we demonstrate the stain-resistance and high pressure stability of superomniphobic flexible optical plastics. A scalable method for creating nano-enoki mushroom-like structures in plastics is presented that provides the re-entrant geometry needed to prevent infiltration from a variety of liquids. The surface demonstrates static contact angles over 150° and low contact angle hysteresis under 20° for a wide variety of organic liquids. The re-entrant tops and fluorination of the nano-enoki as well as the few micron spacing between nanostructures provide robust metastable solid–liquid–air interfaces in the presence of Laplace pressures of at least 900 Pa. In addition, compared to the initial bare plastic, the nano-enoki structures demonstrate comparable transmission values (86.4% versus 88.4% at a wavelength of 550 nm) and ultrahigh haze values (96.4% versus 1.1%). The surfaces exhibit stain-resistance for a variety of liquids including mustard and blood, where mustard and dried blood both flake off the samples without any residue. We also performed durability experiments which demonstrate that nano-enoki plastics are robust to bending with similar transmission, haze, wetting contact angle, and hysteresis values after 5000 cycles of bending.

18 June 2024 in Applied Microbiology
Verified
Journal Article
Open access
PDF file
JEJeremy R Ellis
Jeremy R Ellis
EPEron Justin Powell
Eron Justin Powell
LTLuke Tomasovic
Luke Tomasovic
RMRachel Marcheskie
Rachel Marcheskie
VGVishruth Girish
Vishruth Girish
DSDarshan Sivaloganathan
Darshan Sivaloganathan
The skin microbiome consists of bacteria, fungi, viruses, and mites, which play a crucial role in maintaining skin health and immune function. Imbalances in this microbial community, known as dysbiosis, are implicated in various dermatological conditions. While skincare products are known to influence the skin microbiome, the effects of dermatological procedures have not been extensively studied. Here, we perform a scoping review to outline the studies investigating the impacts of dermatological interventions on the skin microbiome. Phototherapy emerged as the most studied intervention, encompassing UV phototherapy, light therapy, laser therapy, and photodynamic therapy. Chemical interventions, such as chemical peels, micropigmentation, and debridement, have comparatively limited studies describing their impacts on the skin microbiome. To date, no studies have been done on a wide variety of common dermatological procedures such as cryotherapy, skin grafts, and dermabrasion, which may have stronger likelihoods of affecting the skin microbiome. This underscores the need for further research on the influences of dermatological procedures, especially chemical and physical interventions, on the skin microbiome. More comprehensive pre-clinical and clinical studies are essential not only for understanding the long-term consequences of these procedures, but also for optimizing patient outcomes in dermatological care.

18 July 2025 in Journal of Liver Transplantation
Verified
Journal Article
Open access
LTLuke Tomasovic
Luke Tomasovic
JEJeremy R Ellis
Jeremy R Ellis
ASAlexander C. Schulick
Alexander C. Schulick
PAParth Agrawal
Parth Agrawal
AWAnmol Warman
Anmol Warman
EKElizabeth A. King
Elizabeth A. King
Alcohol-related liver disease (ARLD) represents a major cause of end-stage liver disease and has surged as a leading indication for liver transplantation. This study investigates geographic disparities in liver transplant center availability relative to the regional burdens of ARLD mortality and alcohol use disorder (AUD) prevalence in the U.S. Using state-level data from publicly available databases, we evaluated the relationships between liver transplant center density, ARLD mortality, and AUD prevalence. We also developed two novel metrics: the AUD prevalence-to-transplant recipients (AUDT) ratio and the ARLD deaths-to-transplant recipients (ARLDT) ratio. These ratios served as proxies for assessing disparities between the need for and access to liver transplant services. Our findings reveal that while AUD prevalence and AUDT ratios did not significantly vary with transplant center density, higher ARLD mortality per capita and ARLDT ratios were correlated with lower transplant center density. States without a transplant center also experienced significantly higher ARLD mortality per capita compared to states with at least one transplant center per 100,000 square miles. These findings underscore the significant role of geographic factors in accessing transplant care and suggest that barriers to transplant centers may contribute to outcome disparities among patients with ARLD. The study also highlights the need for targeted healthcare planning and policy interventions to enhance liver transplant access, particularly in regions with disproportionately high ARLD burdens and limited transplant infrastructure. Future research should utilize more granular geographies, such as transplant referral regions, and incorporate covariates related to overall healthcare infrastructure and access.

28 March 2025 in Transformative Medicine
Verified
Journal Article
Open access
PDF file
JEJeremy R Ellis
Jeremy R Ellis
LTLuke Tomasovic
Luke Tomasovic
RMRachel Marcheskie
Rachel Marcheskie
By Jeremy R. Ellis, Luke M. Tomasovic, and Rachel L. Marcheskie, Published on 03/28/25